| 1 |
罗洁君，管 宇，范 丽，等. 慢性阻塞性肺疾病临床及影像学表型研究进展[J/CD]. 中华肺部疾病杂志(电子版), 2022, 15(6): 900-903.
|
| 2 |
张 明. 中老年人群慢性阻塞性肺疾病流行状况及影响因素[J]. 中国卫生工程学，2023, 22(1): 63-65+72.
|
| 3 |
Pavic T, Dilber D, Kifer D, et al. N-glycosylation patterns of plasma proteins and immunoglobulin G in chronic obstructive pulmonary disease[J]. J Transl Med, 2018, 16(1): 323.
|
| 4 |
Yu J, Song Y, Tian W. How to select IgG subclasses in developing anti-tumor therapeutic antibodies[J]. J Hematol Oncol, 2020, 13(1): 45.
|
| 5 |
Jing Z, Deng H, Ma J, et al. Expression of immunoglobulin G in human podocytes, and its role in cell viability and adhesion[J]. Int J Mol Med, 2018, 41(6): 3296-3306.
|
| 6 |
Ferri S, Crimi C, Campisi R, et al. Impact of asthma on bronchiectasis severity and risk of exacerbations[J]. J Asthma, 2022, 59(3): 469-475.
|
| 7 |
Fawzy A, Putcha N. Hypogammaglobulinemia in COPD: Treatable Phenotype or Surrogate Marker？[J]. Chest, 2020, 158(4): 1296-1297.
|
| 8 |
沈佩雷，孙攀博，罗 彬. 慢性阻塞性肺病血清IgG亚型水平与急性加重及住院风险的关系[J]. 中国当代医药，2021, 28(14): 43-46.
|
| 9 |
中华医学会，中华医学会杂志社，中华医学会全科医学分会，等. 慢性阻塞性肺疾病基层诊疗指南(2018年)[J]. 中华全科医师杂志，2018, 17(11): 856-870.
|
| 10 |
李 倩，李永哲. 成人血清IgG亚类参考值的建立[J]. 上海医学检验杂志，2001, 16(3): 181-182.
|
| 11 |
Gayle AV, Minelli C, Quint JK. Respiratory-related death in individuals with incident asthma and COPD: a competing risk analysis[J]. BMC Pulm Med, 2022, 22(1): 28.
|
| 12 |
朱卫锋. 中国慢性阻塞性肺疾病管理现状与思考[J]. 上海医药，2023, 44(2): 45-48.
|
| 13 |
Boixeda R, Capdevila JA, Vicente V, et al. Gamma globulin fraction of the proteinogram and chronic obstructive pulmonary disease exacerbations[J]. Med Clin (Barc), 2017, 149(3): 107-113.
|
| 14 |
卢斯霞. 丙种球蛋白作为感染所致的慢性阻塞性肺疾病急性恶化期预后标志物的可行性[J]. 临床与病理杂志，2018, 38(9): 1864-1870.
|
| 15 |
Barton J, Barton C, Bertoli L. Duration of frequent or severe respiratory tract infection in adults before diagnosis of IgG subclass deficiency[J]. PLoS One, 2019, 14(5): e0216940.
|
| 16 |
Wong M, Han YY, Rosser F, et al. Persistent overweight or obesity, lung function, and asthma exacerbations in Puerto Rican youth[J]. Ann Allergy Asthma Immunol, 2022, 128(4): 408-413.e2.
|
| 17 |
Kang J, Park S, Chae EJ, et al. Long-term clinical course and outcomes of immunoglobulin G4-related lung disease[J]. Respir Res, 2020, 21(1): 273.
|
| 18 |
孙 印，何士杰，景卫革，等. 慢性阻塞性肺疾病免疫发病机制研究进展[J]. 医学综述，2019, 25(13): 2574-2578.
|
| 19 |
Stockley RA, Halpin D, Celli BR, et al. Chronic obstructive pulmonary disease biomarkers and their interpretation[J]. Am J Respir Crit Care Med, 2019, 199(10): 1195-1204.
|
| 20 |
Ba Ta T, Tran Viet T, Xuan Nguyen K, et al. Changes in serum immunoglobulin G subclasses during the treatment of patients with chronic obstructive pulmonary disease with infectious exacerbations[J]. Adv Respir Med, 2022, 90(6): 500-510.
|
| 21 |
Palikhe NS, Niven M, Fuhr D, et al. Low immunoglobulin levels affect the course of COPD in hospitalized patients[J]. Allergy Asthma Clin Immunol, 2023, 19(1): 10.
|
| 22 |
Hyun L, Cara K, Andre M, et al. The impact of IgG subclass deficiency on the risk of mortality in hospitalized patients with COPD[J]. Respir Res, 2022, 23(1): 141.
|
| 23 |
Leitao Filho FS, Mattman A, Schellenberg R, et al. Serum IgG levels and risk of COPD hospitalization: A pooled Meta-analysis[J]. Chest, 2020, 158(4): 1420-1430.
|
| 24 |
Leitao Filho FS, Ra SW, Mattman A, et al. Serum IgG subclass levels and risk of exacerbations and hospitalizations in patients with COPD[J]. Respir Res, 2018, 19(1): 30.
|
| 25 |
Barton JC, Clayborn BJ, Bertoli LF, et al. Factors associated with IgG levels in adults with IgG subclass deficiency[J]. BMC Immunol, 2021, 22(1): 53.
|
| 26 |
马印图，陈 莉，张 怡，等. 两种检测血型抗体IgG亚型的方法比较[J]. 河北医学，2020, 26(5): 775-778.
|
| 27 |
丁 航，刘 源，张连峰，等. IgG4相关性疾病的临床特征研究[J]. 中国全科医学，2022, 25(5): 584-588.
|
| 28 |
Sergio LFF, Won RS, Andre M, et al. Serum IgG subclass levels and risk of exacerbations and hospitalizations in patients with COPD[J]. Respir Res, 2018, 19(1): 30.
|
| 29 |
闫 雷，靳德甫，李 畅，等. 血清IgG4水平对常见自身免疫性疾病的鉴别诊断价值[J]. 中国免疫学杂志，2022, 38(5): 604-608, 613.
|
| 30 |
刘英贤，谢燕丕，李惠怡，等. 过敏性哮喘患儿外周血T细胞免疫球蛋白及黏蛋白域4和血清免疫球蛋白G4的水平变化及意义[J]. 中国医药，2020, 15(5): 685-689.
|